Literature DB >> 9788958

Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture.

M C Gershengorn1, E Geras-Raaka, A Varma, I Clark-Lewis.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8, a virus that appears to be involved in the pathogenesis of Kaposi's sarcoma and primary effusion lymphomas, encodes a G protein-coupled receptor (KSHV-GPCR) that exhibits constitutive signaling. In this report, we show that two chemokines, interleukin 8 (IL-8) and growth-related protein-alpha, activate KSHV-GPCR over constitutive levels. Moreover, as with human receptors, the integrity of the ELR motif of these chemokines is required for activation of KSHV-GPCR. Other residues that are required for IL-8 binding to human chemokine receptors CXCR1 and CXCR2 are important for KSHV-GPCR activation also. Thus, it appears that the ELR binding site and other key domains of ELR chemokine activation have been preserved in the virus KSHV-GPCR. The results suggest that KSHV-GPCR originated from CXCR1 or CXCR2 and that activation of KSHV-GPCR by endogenous chemokines may affect the pathobiology of KSHV infection in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788958      PMCID: PMC508995          DOI: 10.1172/JCI4461

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

Review 1.  Reverse intrinsic activity of antagonists on G protein-coupled receptors.

Authors:  W Schütz; M Freissmuth
Journal:  Trends Pharmacol Sci       Date:  1992-10       Impact factor: 14.819

2.  Crystal structure of interleukin 8: symbiosis of NMR and crystallography.

Authors:  E T Baldwin; I T Weber; R St Charles; J C Xuan; E Appella; M Yamada; K Matsushima; B F Edwards; G M Clore; A M Gronenborn
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 3.  CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family.

Authors:  B B Moore; M P Keane; C L Addison; D A Arenberg; R M Strieter
Journal:  J Investig Med       Date:  1998-04       Impact factor: 2.895

Review 4.  Chemokines--chemotactic cytokines that mediate inflammation.

Authors:  A D Luster
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

5.  Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2.

Authors:  S A Jones; B Dewald; I Clark-Lewis; M Baggiolini
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

Review 6.  The oncogenicity of Epstein-Barr virus.

Authors:  G Miller
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

7.  Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide.

Authors:  I Clark-Lewis; B Moser; A Walz; M Baggiolini; G J Scott; R Aebersold
Journal:  Biochemistry       Date:  1991-03-26       Impact factor: 3.162

8.  Three-dimensional structure of interleukin 8 in solution.

Authors:  G M Clore; E Appella; M Yamada; K Matsushima; A M Gronenborn
Journal:  Biochemistry       Date:  1990-02-20       Impact factor: 3.162

9.  Interleukin-8 antagonists generated by N-terminal modification.

Authors:  B Moser; B Dewald; L Barella; C Schumacher; M Baggiolini; I Clark-Lewis
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

10.  Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg.

Authors:  I Clark-Lewis; B Dewald; T Geiser; B Moser; M Baggiolini
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more
  48 in total

Review 1.  Herpesvirus homologues of cellular genes.

Authors:  M Raftery; A Müller; G Schönrich
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.

Authors:  Rizwan Masood; Ethel Cesarman; D Lynne Smith; Parkash S Gill; Ornella Flore
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

3.  Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.

Authors:  Brian R Lane; Jianguo Liu; Paul J Bock; Dominique Schols; Michael J Coffey; Robert M Strieter; Peter J Polverini; David M Markovitz
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse.

Authors:  Hong-Guang Guo; Mariola Sadowska; William Reid; Erwin Tschachler; Gary Hayward; Marvin Reitz
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2.

Authors:  Mark Cannon; Ethel Cesarman; Chris Boshoff
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

Review 6.  The viral etiology of AIDS-associated malignancies.

Authors:  Peter C Angeletti; Luwen Zhang; Charles Wood
Journal:  Adv Pharmacol       Date:  2008

Review 7.  Chemokines as mediators of angiogenesis.

Authors:  Borna Mehrad; Michael P Keane; Robert M Strieter
Journal:  Thromb Haemost       Date:  2007-05       Impact factor: 5.249

Review 8.  Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors.

Authors:  M M Rosenkilde; M J Smit; M Waldhoer
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

Review 9.  Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.

Authors:  Silvia Montaner; Irina Kufareva; Ruben Abagyan; J Silvio Gutkind
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-22       Impact factor: 13.820

Review 10.  Role of CXCL1 in tumorigenesis of melanoma.

Authors:  Punita Dhawan; Ann Richmond
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.